Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Correction To: Programmed Cell Death 1 (Pdcd1) Gene Haplotypes and Susceptibility of Patients to Basal Cell Carcinoma (Molecular Biology Reports, (2021), 48, 3, (2047-2052), 10.1007/S11033-020-06115-W) Publisher Pubmed



Fathi F1 ; Zamani B2 ; Piroozmand A2, 3 ; Mozafarpoor S4 ; Seyedhashemi E5 ; Arefnezhad R6 ; Motedayyen H7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Autoimmune Diseases Research Center, Kashan University of Medical Sciences, Kashan, Iran
  3. 3. Department of Microbiology, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran
  4. 4. Department of Dermatology, Isfahan University of Medical Sciences, Isfahan, Iran
  5. 5. Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
  6. 6. Department of Anatomy, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
  7. 7. Autoimmune Diseases Research Center, Shahid Beheshti Hospital, Kashan University of Medical Sciences, 5th kilometer of Ravand Road, Kashan, Iran

Source: Molecular Biology Reports Published:2021


Abstract

The article Programmed cell death 1 (PDCD1) gene haplotypes and susceptibility of patients to basal cell carcinoma, written by Farshid Fathi, Batool Zamani, Ahmad Piroozmand, Samaneh Mozafarpoor, Effat Seyedhashemi5, Reza ArefNezhad, Hossein Motedayyen was originally published online on the publisher’s internet portal on 22 January 2021 with Open Access under a Creative Commons Attribution (CC BY) license 4.0. With the authors’ decision to cancel Open Access the copyright of the article changed on 26 February 2021 to ©Springer Nature Switzerland BV 2021 with all rights reserved. The original article has been corrected. © 2021, Springer Nature B.V.